Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.89129 | 37 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.84927 | 37 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.85199 | 37 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.78004 | 37 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.77204 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.92403 | 37 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.861 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.8132 | 36 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.81735 | 37 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.83271 | 37 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.83525 | 37 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.82088 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.84723 | 37 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.8379 | 37 |